Top 10 artificial insemination investors in the Nordics
Top 10 artificial insemination investors in the Nordics
The artificial insemination industry in the Nordics is a vibrant sector focused on reproductive health and fertility solutions. Companies range from biotech innovators developing advanced technologies for embryo handling to clinics offering a range of fertility treatments. With a growing awareness of reproductive health issues, there is a notable uptick in demand for services related to IVF and other assisted reproductive technologies. The focus on personalized fertility solutions and technological integration, like apps and wearable devices for tracking ovulation, points towards a more innovative future. This industry is at the intersection of healthcare innovation and social trends, emphasizing the importance of family planning.
The Nordics boast a range of investment firms, including venture capital, private equity, and corporate investors. Predominantly located in Stockholm, Copenhagen, and Frederiksberg, the firms range from small teams to larger organizations investing in varied deal sizes. Founded between 1989 and 2019, these investors collectively engaged in over 70 deals in 2024, demonstrating a robust interest in reproductive health ventures, especially within the artificial insemination sphere. They reflect a strategic blend of capital and expertise, nurturing startups and established players alike.
Top 10 Artificial Insemination Investors in the Nordics
1. Seed Capital Denmark
- Website: seedcapital.dk
- Type: Venture Capital
- Headquarters: Frederiksberg, Frederiksberg, Denmark
- Founded year: 2004
- Headcount: 1-10
- Number of deals in 2024: 5
- LinkedIn: seed-capital-denmark
Seed Capital Denmark is a venture capital firm based in Frederiksberg, Denmark, founded in 2004. The firm specializes in providing seed funding and advisory services to technology startups, primarily in Denmark. While their main focus is on sectors such as SaaS and Fintech, they have also invested in companies within the artificial insemination context. Notably, they participated in funding rounds for EmbryoTrans Biotech, which is involved in embryo-related biotechnology, as well as SwimCount and Observe Medical, which may have applications in reproductive health. This diverse investment strategy showcases their capability to support innovative companies across various sectors, including those related to artificial insemination.
2. Nordic Capital
- Website: nordiccapital.com
- Type: Private Equity
- Headquarters: Stockholm, Stockholm, Sweden
- Founded year: 1989
- Headcount: 201-500
- Number of deals in 2024: 10
- LinkedIn: nordic-capital
Nordic Capital is a private equity firm based in Stockholm, Sweden, founded in 1989. The firm specializes in investments across various sectors, with a strong emphasis on healthcare and technology. Nordic Capital partners with management teams to drive growth and operational improvements in its portfolio companies, focusing on creating long-term value and sustainability. A notable transaction in their portfolio is the acquisition of CARE Fertility, a UK-based fertility clinic group, which they announced on January 31, 2022. This acquisition highlights their commitment to the artificial insemination industry, as CARE Fertility is dedicated to providing fertility treatments. Additionally, Nordic Capital has been involved in other healthcare-related investments, such as the acquisition of Dental Clinics Nederland BV, further showcasing their expertise in the healthcare sector.
3. EQT Ventures
- Website: eqtventures.com
- Type: Venture Capital
- Headquarters: Stockholm, Stockholm, Sweden
- Founded year: 2015
- Headcount: 11-50
- Number of deals in 2024: 28
- LinkedIn: eqt-ventures
EQT Ventures is a venture capital firm based in Stockholm, Sweden, founded in 2015. The firm specializes in investing in early-stage tech startups, providing not only financial support but also operational assistance to entrepreneurs. EQT Ventures connects startups with a global network of industry experts and resources to foster growth and innovation. Among their notable transactions, EQT Ventures led a $30 million Series B funding round for Natural Cycles, a digital contraception and reproductive health company, which focuses on fertility technology. They also participated in a $7 million funding round for Natural Cycles to integrate their fertility technology into Samsung's Galaxy Watch5 series. These investments highlight EQT Ventures' engagement in the women's health and reproductive technology sectors, aligning with interests in artificial insemination and related fields.
4. Bonnier Ventures
- Website: bonnierventures.com
- Type: Venture Capital
- Headquarters: Stockholm, Stockholm, Sweden
- Founded year: 2013
- Headcount: 1-10
- Number of deals in 2024: 1
- LinkedIn: bonnier-ventures
Bonnier Ventures is a venture capital firm based in Stockholm, Sweden, founded in 2013. As the investment division of the Bonnier Group, it focuses on providing capital and management support to promising companies in structurally growing industries, including healthcare, media, sustainability, fintech, and SaaS. Notably, Bonnier Ventures has participated in funding rounds for Natural Cycles, a leading women's health company that specializes in digital contraception and reproductive health. Their investments in Natural Cycles include a Series B funding round of $30 million in 2017, a Series C round of $55 million in 2024, and earlier rounds that contributed to the company's growth and development of fertility technology. This involvement highlights Bonnier Ventures' commitment to supporting innovations in women's health, which is closely related to the artificial insemination sector.
5. Lundbeckfonden / Lundbeck Foundation
- Website: lundbeckfonden.com
- Type: Venture Capital
- Headquarters: Copenhagen, Denmark
- Founded year: 1954
- Headcount: 11-50
- Number of deals in 2024: 1
- LinkedIn: lundbeckfonden
Lundbeckfonden / Lundbeck Foundation is a not-for-profit organization based in Copenhagen, Denmark, founded in 1954. It is dedicated to funding health science research, particularly in brain-related studies, and provides various grants and scholarships to researchers and academic institutions in Denmark. The foundation plays a crucial role in supporting the translation and commercialization of groundbreaking science. Recently, Lundbeckfonden BioCapital, in collaboration with +ND Capital, invested EUR 5M in Notify Therapeutics, a Danish biotech company focused on developing a non-hormonal fertility treatment for women with diminished ovarian reserve. This investment highlights the foundation's engagement in the fertility sector, showcasing its commitment to advancing scientific knowledge and innovation in healthcare, including reproductive health.
6. Vitrolife, Part of Vitrolife Group
- Website: vitrolife.com
- Type: Corporate
- Headquarters: Sweden
- Founded year: 1994
- Headcount: 1001-5000
- LinkedIn: vitrolife
Vitrolife, part of the Vitrolife Group, is a corporate investor based in Sweden, founded in 1994. The company specializes in reproductive health, providing a comprehensive range of products and services tailored for in vitro fertilization (IVF) processes. Their offerings include labware, culture media, and cryopreservation solutions, all aimed at IVF clinics and healthcare professionals. Vitrolife's mission is to enhance the success rates of assisted reproduction treatments through innovative products. A notable transaction in their portfolio is the acquisition of OCTAX Microscience GmbH and MTG Medical Technology Vertriebs-GmbH in June 2016, which significantly bolstered their market position within the IVF sector, indicating their active role in the artificial insemination industry.
7. Trill Impact
- Website: trillimpact.com
- Type: Private Equity
- Headquarters: Stockholm, Stockholm, Sweden
- Founded year: 2019
- Headcount: 51-200
- Number of deals in 2024: 1
- LinkedIn: trill-impact
Trill Impact is an impact investment firm based in Stockholm, Sweden, founded in 2019. The firm specializes in private equity, ventures, and microfinance, with a strong commitment to creating measurable social and environmental impact alongside competitive financial returns. Trill Impact's clients include institutional investors and businesses looking to invest in initiatives that drive positive change. A notable transaction by Trill Impact is their participation in the Series B funding round for May Health, which raised $25 million to advance its Ovarian Rebalancing therapy aimed at addressing PCOS-related infertility. This investment highlights Trill Impact's engagement in the reproductive health sector, particularly in areas that intersect with artificial insemination and fertility treatments.
8. Heartcore Capital
- Website: heartcore.com
- Type: Venture Capital
- Headquarters: Copenhagen, Denmark
- Founded year: 2007
- Headcount: 11-50
- Number of deals in 2024: 17
- LinkedIn: heartcorecapital
Heartcore Capital is a venture capital firm based in Copenhagen, Denmark, founded in 2007. The firm specializes in investing in early-stage technology companies and emphasizes building long-term relationships with entrepreneurs. In 2024, Heartcore Capital has been active in the investment landscape, participating in 17 transactions. Notably, they have invested in Natural Cycles, a leading women's health company that focuses on digital contraception and reproductive health. Natural Cycles has raised significant funding over the years, including a $55 million Series C round in May 2024, which highlights the growing interest and market potential in fertility technology. Their previous funding rounds, including a $30 million Series B and a $6 million Series A, further demonstrate Heartcore's commitment to supporting innovations in women's health and fertility, aligning with the interests of artificial insemination investors.
9. EQT Foundation
- Website: eqtfoundation.com
- Type: Corporate
- Headquarters: Stockholm, Stockholm, Sweden
- Founded year: 2019
- Headcount: 1-10
- Number of deals in 2024: 3
- LinkedIn: eqt-foundation
EQT Foundation is a not-for-profit organization based in Stockholm, Sweden, founded in 2019. It focuses on supporting innovative research and early-stage impact companies, providing grants and investments to entrepreneurs and researchers tackling critical challenges in climate and health. The foundation aims to empower its ecosystem to contribute positively to society while safeguarding EQT's values. In 2023, EQT Foundation participated in a seed funding round for Fertifa, a reproductive health startup that raised $6.3 million. This investment highlights the foundation's interest in advancing reproductive health solutions, which are closely related to artificial insemination and fertility services. By backing Fertifa, EQT Foundation demonstrates its commitment to enhancing health outcomes and supporting innovations in the reproductive health sector.
10. Reiten & Co
- Website: reitenco.com
- Type: Private Equity
- Headquarters: Oslo, Oslo, Norway
- Founded year: 1992
- Headcount: 11-50
- LinkedIn: reiten-&-co
Reiten & Co is a private equity investment firm based in Oslo, Norway, founded in 1992. The firm specializes in private equity and investment management, focusing on developing Nordic companies by providing them with capital and strategic support to enhance their growth potential. Their clientele spans various sectors, including environmental services and healthcare. Notably, Reiten & Co acquired Ellipse-Klinikken on November 3, 2006, which is a significant transaction in the healthcare sector. This acquisition indicates their involvement in the healthcare industry, which may include services related to artificial insemination, although the specific focus of Ellipse-Klinikken on reproductive health services is not explicitly detailed.
Artificial Insemination Insights: Key Investors in the Nordics
| Investor | Headquarter | Size | Founded | Deals 2024 |
|---|---|---|---|---|
| Seed Capital Denmark | Frederiksberg, Frederiksberg, Denmark | 1-10 | 2004 | 5 |
| Nordic Capital | Stockholm, Stockholm, Sweden | 201-500 | 1989 | 10 |
| EQT Ventures | Stockholm, Stockholm, Sweden | 11-50 | 2015 | 28 |
| Bonnier Ventures | Stockholm, Stockholm, Sweden | 1-10 | 2013 | 1 |
| Lundbeckfonden / Lundbeck Foundation | Copenhagen, Denmark | 11-50 | 1954 | 1 |
| Vitrolife, Part of Vitrolife Group | Sweden | 1001-5000 | 1994 | 0 |
| Trill Impact | Stockholm, Stockholm, Sweden | 51-200 | 2019 | 1 |
| Heartcore Capital | Copenhagen, Denmark | 11-50 | 2007 | 17 |
| EQT Foundation | Stockholm, Stockholm, Sweden | 1-10 | 2019 | 3 |
| Reiten & Co | Oslo, Oslo, Norway | 11-50 | 1992 | 0 |
Want to find more investors focusing on the artificial insemination industry?
If you want to find more investors that are active in the artificial inseminationindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and there are a lot more private equity, venturecapital, and corporate investors like these globally.With Inven, you'll also get to know:
- Deal History: Number of deals and their sizes.
- Portfolio: Companies they've invested in.
- Contact data: Key dealmakers, including their emails and phonenumbers.
- ...and much more!
.jpg)
Trusted by 700+ companies
